Evolution of Bacterial Pathogens Within the Human Host.

Selective pressures within the human host, including interactions with innate and adaptive immune responses, exposure to medical interventions such as antibiotics, and competition with commensal microbiota all facilitate the evolution of bacterial pathogens. In this chapter, we present examples of pathogen strategies that emerged as a result of selective pressures within the human host niche and discuss the resulting coevolutionary "arms race" between these organisms. In bacterial pathogens, many of the genes responsible for these strategies are encoded on mobile pathogenicity islands or plasmids, underscoring the importance of horizontal gene transfer in the emergence of virulent microbial species.

[1]  E. Kemen,et al.  Host-microbe and microbe-microbe interactions in the evolution of obligate plant parasitism. , 2015, The New phytologist.

[2]  W. S. Lakra,et al.  Multidrug Efflux Pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus Bacterial Food Pathogens , 2015, International journal of environmental research and public health.

[3]  M. Blokesch,et al.  The type VI secretion system of Vibrio cholerae fosters horizontal gene transfer , 2015, Science.

[4]  Gemma C. Langridge,et al.  Patterns of genome evolution that have accompanied host adaptation in Salmonella , 2014, Proceedings of the National Academy of Sciences.

[5]  M. Webber,et al.  Molecular mechanisms of antibiotic resistance , 2014, Nature Reviews Microbiology.

[6]  P. Sansonetti,et al.  B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection , 2014, The Journal of experimental medicine.

[7]  Y. Abu Kwaik,et al.  Amoeba host-Legionella synchronization of amino acid auxotrophy and its role in bacterial adaptation and pathogenic evolution. , 2014, Environmental microbiology.

[8]  S. B. Peterson,et al.  Type VI secretion system effectors: poisons with a purpose , 2014, Nature Reviews Microbiology.

[9]  R. Rappuoli,et al.  Neisseria meningitidis NalP cleaves human complement C3, facilitating degradation of C3b and survival in human serum , 2013, Proceedings of the National Academy of Sciences.

[10]  M. Trost,et al.  Proteomic Identification of Novel Secreted Antibacterial Toxins of the Serratia marcescens Type VI Secretion System* , 2013, Molecular & Cellular Proteomics.

[11]  Olivier Disson,et al.  Concepts and mechanisms: crossing host barriers. , 2013, Cold Spring Harbor perspectives in medicine.

[12]  David A Low,et al.  Rhs proteins from diverse bacteria mediate intercellular competition , 2013, Proceedings of the National Academy of Sciences.

[13]  Paul A. Wiggins,et al.  Diverse type VI secretion phospholipases are functionally plastic antibacterial effectors , 2013, Nature.

[14]  Janice K. Wiedenbeck,et al.  Origins of bacterial diversity through horizontal genetic transfer and adaptation to new ecological niches. , 2011, FEMS microbiology reviews.

[15]  Waldemar Vollmer,et al.  Type VI secretion delivers bacteriolytic effectors to target cells , 2011, Nature.

[16]  Philip Sutton,et al.  Mucin dynamics and enteric pathogens , 2011, Nature Reviews Microbiology.

[17]  Eric P. Skaar,et al.  The Battle for Iron between Bacterial Pathogens and Their Vertebrate Hosts , 2010, PLoS pathogens.

[18]  Christina Toft,et al.  Evolutionary microbial genomics: insights into bacterial host adaptation , 2010, Nature Reviews Genetics.

[19]  J. Taubenberger,et al.  Influenza virus evolution, host adaptation, and pandemic formation. , 2010, Cell host & microbe.

[20]  Sebastian Bonhoeffer,et al.  Compensation of Fitness Costs and Reversibility of Antibiotic Resistance Mutations , 2010, Antimicrobial Agents and Chemotherapy.

[21]  Diarmaid Hughes,et al.  Antibiotic resistance and its cost: is it possible to reverse resistance? , 2010, Nature Reviews Microbiology.

[22]  J. Sha,et al.  A Type VI Secretion System Effector Protein, VgrG1, from Aeromonas hydrophila That Induces Host Cell Toxicity by ADP Ribosylation of Actin , 2009, Journal of bacteriology.

[23]  A. Hauser.  The type III secretion system of Pseudomonas aeruginosa: infection by injection , 2009, Nature Reviews Microbiology.

[24]  H. Gingras,et al.  Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance. , 2009, Genome research.

[25]  N. Mideo.  Parasite adaptations to within-host competition. , 2009, Trends in parasitology.

[26]  B. Klein,et al.  Fungal adaptation to the mammalian host: it is a new world, after all. , 2008, Current opinion in microbiology.

[27]  S. Tsukita,et al.  Tight junction-based epithelial microenvironment and cell proliferation , 2008, Oncogene.

[28]  Frank Schluenzen,et al.  The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning , 2008, Proceedings of the National Academy of Sciences.

[29]  P. Gajer,et al.  The Pangenome Structure of Escherichia coli: Comparative Genomic Analysis of E. coli Commensal and Pathogenic Isolates , 2008, Journal of bacteriology.

[30]  F. Navarro-Garcia,et al.  The serine protease motif of Pic mediates a dose-dependent mucolytic activity after binding to sugar constituents of the mucin substrate. , 2008, Microbial pathogenesis.

[31]  M. Hollingsworth,et al.  Relevance of MUC1 mucin variable number of tandem repeats polymorphism in H pylori adhesion to gastric epithelial cells. , 2008, World journal of gastroenterology.

[32]  V. Korolik,et al.  Mucins in the mucosal barrier to infection , 2008, Mucosal Immunology.

[33]  John D. Lambris,et al.  Complement evasion by human pathogens , 2008, Nature Reviews Microbiology.

[34]  A. Vella,et al.  Salmonella Flagellin Induces Bystander Activation of Splenic Dendritic Cells and Hinders Bacterial Replication In Vivo1 , 2007, The Journal of Immunology.

[35]  M. McGuckin,et al.  Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. , 2007, Gastroenterology.

[36]  David R. Liu,et al.  The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2 , 2006, Proceedings of the National Academy of Sciences.

[37]  D. Mengin-Lecreulx,et al.  Colicin M Exerts Its Bacteriolytic Effect via Enzymatic Degradation of Undecaprenyl Phosphate-linked Peptidoglycan Precursors* , 2006, Journal of Biological Chemistry.

[38]  W. Nelson,et al.  Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Robert B Sim,et al.  Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases , 2005, Nature Immunology.

[40]  Gerard D. Wright,et al.  Bacterial resistance to antibiotics: enzymatic degradation and modification. , 2005, Advanced drug delivery reviews.

[41]  G. Moore,et al.  Rapid Detection of Colicin E9-Induced DNA Damage Using Escherichia coli Cells Carrying SOS Promoter-lux Fusions , 2005, Journal of bacteriology.

[42]  Benjamin P. Westover,et al.  Glycan Foraging in Vivo by an Intestine-Adapted Bacterial Symbiont , 2005, Science.

[43]  Long-Fei Wu,et al.  Bactericidal Activity of Colicin V Is Mediated by an Inner Membrane Protein, SdaC, of Escherichia coli , 2005, Journal of bacteriology.

[44]  W. V. van Wamel,et al.  Anti-opsonic properties of staphylokinase. , 2005, Microbes and infection.

[45]  H. Baker,et al.  MucA-Mediated Coordination of Type III Secretion and Alginate Synthesis in Pseudomonas aeruginosa , 2004, Journal of bacteriology.

[46]  H. Gold,et al.  Antimicrobial resistance to linezolid. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  R. Haas,et al.  Helicobacter pylori Vacuolating Cytotoxin Inhibits T Lymphocyte Activation , 2003, Science.

[48]  B. Charlesworth,et al.  Biological and biomedical implications of the co-evolution of pathogens and their hosts , 2002, Nature Genetics.

[49]  R. Strong,et al.  The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. , 2002, Molecular cell.

[50]  M. Hornef,et al.  Bacterial strategies for overcoming host innate and adaptive immune responses , 2002, Nature Immunology.

[51]  M. Aepfelbacher,et al.  Identification of the Staphylococcus aureus etd Pathogenicity Island Which Encodes a Novel Exfoliative Toxin, ETD, and EDIN-B , 2002, Infection and Immunity.

[52]  Y. Hanakawa,et al.  Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome. , 2002, The Journal of clinical investigation.

[53]  L. Vinall,et al.  Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. , 2002, Gastroenterology.

[54]  H. Ochman,et al.  Lateral gene transfer and the nature of bacterial innovation , 2000, Nature.

[55]  J. Nataro,et al.  Characterization of Pic, a Secreted Protease ofShigella flexneri and EnteroaggregativeEscherichia coli , 1999, Infection and Immunity.

[56]  A. Franco,et al.  Molecular Evolution of the Pathogenicity Island of Enterotoxigenic Bacteroides fragilis Strains , 1999, Journal of bacteriology.

[57]  E. Groisman,et al.  The selC‐associated SHI‐2 pathogenicity island of Shigella flexneri , 1999, Molecular microbiology.

[58]  C. Sears,et al.  Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Harty,et al.  Interactions of the Invasive PathogensSalmonella typhimurium, Listeria monocytogenes, and Shigella flexneri with M Cells and Murine Peyer’s Patches , 1998, Infection and Immunity.

[60]  W. Whitman,et al.  Prokaryotes: the unseen majority. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[61]  V. Deretic,et al.  Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection , 1997, Infection and immunity.

[62]  J. Davies,et al.  Origins and Evolution of Antibiotic Resistance , 1996, Microbiology and Molecular Biology Reviews.

[63]  S. Falkow,et al.  Entry of microbes into the host: using M cells to break the mucosal barrier. , 1995, Current opinion in immunology.

[64]  J. Frère,et al.  Beta‐lactamases and bacterial resistance to antibiotics , 1995, Molecular microbiology.

[65]  M. Parker,et al.  Uncoupled steps of the colicin A pore formation demonstrated by disulfide bond engineering. , 1994, The Journal of biological chemistry.

[66]  H. L. Vos,et al.  The mouse episialin (Muc1) gene and its promoter: rapid evolution of the repetitive domain in the protein. , 1991, Biochemical and biophysical research communications.

[67]  V. Braun,et al.  Binding of the immunity protein inactivates colicin M , 1991, Molecular microbiology.

[68]  V. Braun,et al.  Colicin M inhibits peptidoglycan biosynthesis by interfering with lipid carrier recycling. , 1989, The Journal of biological chemistry.

[69]  M. P. Jackson,et al.  Cloning and expression of the exfoliative toxin B gene from Staphylococcus aureus , 1986, Journal of bacteriology.

[70]  J. Krebs,et al.  Arms races between and within species , 1979, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[71]  H. Rogers.  Iron-Binding Catechols and Virulence in Escherichia coli , 1973, Infection and immunity.

[72]  T. Boon.  Inactivation of ribosomes in vitro by colicin E 3 and its mechanism of action. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[73]  R. Hinsdill,et al.  Characterization of a Staphylococcus aureus Bacteriocin , 1970, Journal of bacteriology.

[74]  George C. Williams,et al.  PLEIOTROPY, NATURAL SELECTION, AND THE EVOLUTION OF SENESCENCE , 1957, Science of Aging Knowledge Environment.

[75]  B. Koskella,et al.  6 – Coevolution of Host and Pathogen , 2011 .

[76]  J. Hacker,et al.  The Contribution of Pathogenicity Islands to the Evolution of Bacterial Pathogens , 2006 .